Incretins (GLP1 r agonists and dual, triple agonists) and the liver
Dhillon (2002)
Monitoreo y ajuste continuo: El seguimiento regular del peso, glucosa en sangre (si aplica), presin arterial y otros parmetros metablicos permite deteccin temprana de recuperacin de peso o deterioro glucmico
Considerations that typically inform the decision include: Primary goal: weight management, glycemic control, or both Tolerability: how each medication's side effects affect you personally Medical history: contraindications, comorbidities, and concurrent medications Cardiovascular data: semaglutide has longer-established outcome evidence Access and cost: insurance coverage, pricing, and local supply Formulation preference: injection versus, for semaglutide, an oral diabetes option A practical way to think about it: tirzepatide's dual mechanism gives it an edge in average efficacy, while semaglutide offers a longer real-world track record and additional formulation flexibility
A provider that responds defensively, dismisses complaints, or doesn't respond at all may have service quality issues that extend beyond the specific complaint